DaVita Inc. (DVA) Q4 2017 Earnings Conference Call Transcript
DVA earnings call for the period ending December 31, 2017.
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
Key Data Points
Primary metrics and data points about DaVita.| Current Price: | $67.89 |
| Prev Close: | $66.99 |
| Open: | $66.39 |
| Bid: | $65.00 |
| Ask: | $71.78 |
| Day's Range: | $65.69 - $67.97 |
| 52wk Range: | $52.51 - $80.71 |
| Volume: | 1,266,473 |
| Avg Vol | 1,560,151 |
| Market Cap: | $12B |
| P/E (ttm): | 17.35 |
| EPS (ttm): | $3.86 |
| Div & Yield: | $0.00 (0.0%) |
Company Rating
What our community thinks about DaVita.
CAPS Rating
CAPS All Stars
Powered by 
CEO Rating
The single most important factor in a company's success is the team that's leading the company.
Kent J. Thiry, CEO
74% Approve
Based on 1249 Ratings
Business Summary
Industry, sector and description for DaVita.The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
- Exchange: NYSE
- Sector: Healthcare
- Industry: Healthcare IT